CANF Can-Fite BioPharma Ltd.
NEUTRAL
Impact: 2/10
6-K
Notable filing: 6-K
Price Chart
Loading chart...
Executive Summary
Can-Fite BioPharma reported that its Annual General Meeting of Shareholders held on June 4, 2026, approved all five proposals put to a vote. The proposals were previously detailed in the company's proxy statement filed on April 23, 2026. This is a routine governance filing with no material financial or operational impact.
Actionable Insight
No immediate trading action warranted. Monitor the company's next operational update or pipeline milestone for material catalysts.
Key Facts
- Annual General Meeting held on June 4, 2026.
- All five proposals were approved by the required majority.
- Proposals were described in the proxy statement dated April 23, 2026.
Financial Impact
No financial figures disclosed; routine shareholder vote.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (8 analysts)
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-065311 |
| Document: 0001213900-26-065311-index-headers.html | 0001213900-26-065311 |
| Document: 0001213900-26-065311-index.html | 0001213900-26-065311 |
| Document: 0001213900-26-065311.txt | 0001213900-26-065311 |
14 reports for CANF
100%
Hit rate
best @ T+20▲ +5.33%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
8d ago
|
6-K
| $3.20 awaiting T+1 | awaiting T+1 | — | $2.84 (−11.25%) |
|
Jun 2, 2026
10d ago
|
6-K
| $3.11 $3.11 | · 0.00% | ▲ +0.69% | $2.84 (−8.68%) |
|
May 28, 2026
15d ago
|
6-K
| $3.35 $3.24 | ▼ −3.28% | ▼ −3.54% | $2.84 (−15.22%) |
|
May 13, 2026
4w ago
|
6-K
| $3.64 $3.49 | ▼ −4.12% | ▼ −4.90% | $2.84 (−21.98%) |
|
Apr 30, 2026
6w ago
|
6-K
| $3.19 $2.93 | ▼ −8.15% | ▼ −8.37% | $2.84 (−10.97%) |
|
Apr 23, 2026
7w ago
|
6-K
| $2.91 $2.92 | ▲ +0.34% | ▲ +0.18% | $2.84 (−2.41%) |
|
Apr 6, 2026
9w ago
|
EFFECT
| $3.06 $3.03 | ▼ −0.98% | ▼ −1.04% | $2.84 (−7.19%) |
|
Apr 1, 2026
10w ago
|
EFFECT
| $3.09 $3.07 | ▼ −0.65% | ▼ −0.73% | $2.84 (−8.09%) |
|
Mar 30, 2026
10w ago
|
6-K
| $3.01 $3.10 | ▲ +2.99% | ▲ +0.10% | $2.84 (−5.65%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $3.01 $3.10 | ▲ +2.99% | ▲ +0.10% | $2.84 (−5.65%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Mon (53h 8m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access